Sensitive HIV-1 DNA Pol Next-Generation Sequencing for the Characterisation of Archived Antiretroviral Drug Resistance
Viruses · 2023
DOI: 10.3390/v15091811 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Johannes C Botha und 12 weiteren Autor:innen. Beteiligte Einrichtung: Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, Anti-HIV Agents, HIV Seropositivity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, D3/Penta 21 trial, ViiV Healthcare.
Abstract (Originalsprache)
Modern HIV-1 treatment effectively suppresses viral amplification in people living with HIV. However, the persistence of HIV-1 DNA as proviruses integrated into the human genome remains the main barrier to achieving a cure. Next-generation sequencing (NGS) offers increased sensitivity for characterising archived drug resistance mutations (DRMs) in HIV-1 DNA for improved treatment options. In this study, we present an ultra-sensitive targeted PCR assay coupled with NGS and a robust pipeline to characterise HIV-1 DNA DRMs from buffy coat samples. Our evaluation supports the use of this assay for Pan-HIV-1 analyses with reliable detection of DRMs across the HIV-1 Pol region. We propose this assay as a new valuable tool for monitoring archived HIV-1 drug resistance in virologically suppressed individuals, especially in clinical trials investigating novel therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK.
- Advanced Pathogen Diagnostics Unit, University College London Hospitals NHS Trust, London NW1 2PG, UK.
- Health Services Laboratories, London WC1H 9AX, UK.
- ViiV Healthcare, Durham, NC 27709, USA.
- Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
- Medical Research Council Clinical Trials Unit, University College London, London WC1E 6BT, UK.
ORCID-Profile: Johannes C Botha, Anna Turkova
Förderung
- Medical Research Council
- D3/Penta 21 trial
- ViiV Healthcare
- UCLH APDU
- UK Medical Research Council core funding
Zitieren
APA
Botha, J. C., Byott, M., Spyer, M. J., Grant, P. R., Gärtner, K., Chen, W. X., Burton, J., Bamford, A., Waters, L. J., Giaquinto, C., Turkova, A., Vavro, C. L., & Nastouli, E. (2023). Sensitive HIV-1 DNA Pol Next-Generation Sequencing for the Characterisation of Archived Antiretroviral Drug Resistance. Viruses. https://doi.org/10.3390/v15091811
Vancouver
Botha JC, Byott M, Spyer MJ, Grant PR, Gärtner K, Chen WX, et al. Sensitive HIV-1 DNA Pol Next-Generation Sequencing for the Characterisation of Archived Antiretroviral Drug Resistance. Viruses. 2023. doi:10.3390/v15091811
BibTeX
@article{Botha2023,
author = {Botha, Johannes C and Byott, Matthew and Spyer, Moira J and Grant, Paul R and Gärtner, Kathleen and Chen, Wilson X and Burton, James and Bamford, Alasdair and Waters, Laura J and Giaquinto, Carlo and Turkova, Anna and Vavro, Cindy L and Nastouli, Eleni},
title = {Sensitive HIV-1 DNA Pol Next-Generation Sequencing for the Characterisation of Archived Antiretroviral Drug Resistance},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15091811}
}
EUVIMED